Calmodulin inhibition contributes to sensitize TRAIL-induced apoptosis in human lung cancer H1299 cells

Biochemistry and Cell Biology

Volumn 87, Issue 6, 2009, Pages 919-926

  Hwang, Mi Kyung ^a   Min, Yong Ki ^a   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Apoptosis; Calmodulin antagonists; Fluphenazine N 2 chloroethane; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

AKT PHOSPHORYLATION; APOPTOSIS; APOPTOTIC; CASPASES; CONVERTING ENZYME; DEATH-INDUCING SIGNALING COMPLEXES; ENZYME INHIBITORS; FAS-ASSOCIATED DEATH DOMAINS; FLUPHENAZINE-N-2-CHLOROETHANE; HUMAN LUNG; IN-CELL; INDUCED APOPTOSIS; INHIBITOR OF APOPTOSIS PROTEINS; INHIBITORY PROTEINS; INTERLEUKIN-1; LUNG CANCER; LUNG CANCER CELLS; THERAPEUTIC POTENTIALS; TUMOR CELLS; TUMOR NECROSIS FACTORS;

BIOLOGICAL ORGANS; CALMODULIN; CAMS; ENZYMES; GLYCOPROTEINS; LIGANDS; MACROPHAGES; PHOSPHORYLATION; TUMORS;

CELL DEATH;

CALMODULIN; CALMODULIN INHIBITOR; CASPASE 8; FLICE INHIBITORY PROTEIN; FLUPHENAZINE N 2 CHLOROETHENE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LUNG CANCER; SIGNAL TRANSDUCTION;

APOPTOSIS; CALMODULIN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASES; CELL LINE, TUMOR; ENZYME ACTIVATION; FLUPHENAZINE; HUMANS; LUNG NEOPLASMS; MOLECULAR STRUCTURE; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 74549185974     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/O09-058     Document Type: Article

References (28)

1. Ashkenazi, A. 2002. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer, 2(6): 420-430. doi:10.1038/nrc821. PMID:12189384.
2. Bartolomé, F., de Las Cuevas, N., Muñoz, U., Bermejo, F., and Martín-Requero, A. 2007. Impaired apoptosis in lymphoblasts from Alzheimer's disease patients: cross-talk of Ca2+/calmodulin and ERK1/2 signaling pathways. Cell. Mol. Life Sci. 64(11): 1437-1448. doi:10.1007/s00018- 007-7081-3. PMID:17502994.
3. Chawla-Sarkar, M., Bae, S.I., Reu, F.J., Jacobs, B.S., Lindner, D.J., and Borden, E.C. 2004. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 11(8): 915-923. doi:10.1038/sj.cdd.4401416. PMID:15118763.
4. Chen, Y., Pawar, P., Pan, G., Ma, L., Liu, H., and McDonald, J.M. 2008. Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells. J. Cell. Biochem. 103(3): 788-799. doi:10.1002/jcb.21447. PMID: 17654480.
5. Cheung, W.Y. 1980. Calmodulin plays a pivotal role in cellular regulation. Science, 207(4426): 19-27. doi:10.1126/science. 6243188. PMID:6243188.
6. Cohen, G.M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326(Pt 1): 1-16. PMID:9337844.
7. Coticchia, C.M., Revankar, C.M., Deb, T.B., Dickson, R.B., and Johnson, M.D. 2009. Calmodulin modulates Akt activity in human breast cancer cell lines. Breast Cancer Res. Treat. 115(3): 545-560. doi:10.1007/s10549-008-0097-z. PMID:18587642.
8. Cross, T.G., Scheel-Toellner, D., Henriquez, N.V., Deacon, E., Salmon, M., and Lord, J.M. 2000. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256(1): 34-41. doi:10.1006/excr. 2000.4836. PMID:10739649.
9. Deb, T.B., Coticchia, C.M., and Dickson, R.B. 2004. Calmodulinmediated activation of Akt regulates survival of c-Myc-overexpressing mouse mammary carcinoma cells. J. Biol. Chem. 279(37): 38903-38911. doi:10.1074/jbc.M405314200. PMID: 15247222.
10. Hait, W.N., and Lazo, J.S. 1986. Calmodulin: a potential target for cancer chemotherapeutic agents. J. Clin. Oncol. 4(6): 994-1012. PMID:2423656.
11. Hait, W.N., Glazer, L., Kaiser, C., Cross, J., and Kennedy, K.A. 1987. Pharmacological properties of fluphenazine-mustard, an irreversible calmodulin antagonist. Mol. Pharmacol. 32(3): 404-409. PMID:3670276.
12. Inoue, T., Shiraki, K., Fuke, H., Yamanaka, Y., Miyashita, K., Yamaguchi, Y., et al. 2006. Proteasome inhibition sensitizes hepatocellular carcinoma cells to TRAIL by suppressing caspase inhibitors and AKT pathway. Anticancer Drugs, 17(3): 261-268. doi:10.1097/00001813-200603000-00004. PMID:16520654.
13. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature, 388(6638): 190-195. doi:10.1038/40657. PMID:9217161.
14. Ito, H., Wang, J.Z., and Shimura, K. 1991. Inhibition of lung metastasis by a calmodulin antagonist, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), in mice bearing Lewis lung carcinoma. Anticancer Res. 11(1): 249-252. PMID: 2018358.
15. Jin, C.Y., Moon, D.O., Lee, J.D., Heo, M.S., Choi, Y.H., Lee, C.M., et al. 2007. Sulforaphane sensitizes tumor necrosis factorrelated apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells. Carcinogenesis, 28(5): 1058-1066. doi:10.1093/carcin/bgl251. PMID:17183064.
16. LeBlanc, H.N., and Ashkenazi, A. 2003. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ. 10(1): 66-75. doi:10.1038/sj.cdd. 4401187. PMID:12655296.
17. Lee, B.H., and Ruoslahti, E. 2005. a5b1 integrin stimulates Bcl-2 expression and cell survival through Akt, focal adhesion kinase, and Ca2+/calmodulin-dependent protein kinase IV. J. Cell. Biochem. 95(6): 1214-1223. doi:10.1002/jcb.20488. PMID:15962308.
18. Li, H., Wang, X., Li, N., Qiu, J., Zhang, Y., and Cao, X. 2007. hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways. J. Biol. Chem. 282(7): 4943-4950. doi:10.1074/jbc.M609494200. PMID:17178731.
19. Panka, D.J., Mano, T., Suhara, T., Walsh, K., and Mier, J.W. 2001. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J. Biol. Chem. 276(10): 6893-6896. doi:10.1074/jbc.C000569200. PMID:11145953.
20. Pawar, P.S., Micoli, K.J., Ding, H., Cook, W.J., Kappes, J.C., Chen, Y., and McDonald, J.M. 2008. Calmodulin binding to cellular FLICE-like inhibitory protein modulates Fas-induced signalling. Biochem. J. 412(3): 459-468. doi:10.1042/BJ20071507. PMID:18257744.
21. Roth, W., Isenmann, S., Naumann, U., Kügler, S., Bähr, M., Dichgans, J., et al. 1999. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem. Biophys. Res. Commun. 265(2): 479-483. doi:10.1006/bbrc.1999.1693. PMID:10558893.
22. Schimmer, A.D. 2004. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res. 64(20): 7183-7190. doi:10.1158/0008-5472.CAN-04-1918. PMID:15492230.
23. Seol, J.W., Lee, Y.J., Kang, H.S., Kim, I.S., Kim, N.S., Kwak, Y.G., et al. 2005. Wortmannin elevates tumor necrosis factor-related apoptosis-inducing ligand sensitivity in LNCaP cells through down-regulation of IAP-2 protein. Exp. Oncol. 27(2): 120-124. PMID:15995629.
24. Tazzari, P.L., Tabellini, G., Ricci, F., Papa, V., Bortul, R., Chiarini, F., et al. 2008. Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells. Cancer Res. 68(22): 9394-9403. doi:10.1158/0008-5472.CAN-08-2815. PMID:19010914.
25. Thermos, K., Winkler, J.D., and Weiss, B. 1987. Comparison of the effects of fluphenazine-N-mustard on dopamine binding sites and on behavior induced by apomorphine in supersensitive mice. Neuropharmacology, 26(10): 1473-1480. doi:10.1016/0028-3908(87)90166-3. PMID:3120028.
26. Veigl, M.L., Vanaman, T.C., and Sedwick, W.D. 1984. Calcium and calmodulin in cell growth and transformation. Biochim. Biophys. Acta, 738(1-2): 21-48. PMID:6331500.
27. Vogler, M., Walczak, H., Stadel, D., Haas, T.L., Genze, F., Jovanovic, M., et al. 2008. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. Cancer Res. 68(19): 7956-7965. doi:10.1158/0008-5472.CAN-08-1296. PMID:18829553.
28. Walczak, H., Miller, R.E., Ariail, K., Gliniak, B., Griffith, T.S., Kubin, M., et al. 1999. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5(2): 157-163. doi:10.1038/5517. PMID:9930862.